Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies-Reference-Cited by-同舟云学术

Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies

Published:2022-07 Issue: Volume:63 Page:103927
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Masanneck Lars^ORCID,Rolfes Leoni,Regner-Nelke Liesa,Willison Alice,Räuber Saskia,Steffen Falk,Bittner Stefan,Zipp Frauke,Albrecht Philipp,Ruck Tobias,Hartung Hans-Peter,Meuth Sven G.,Pawlitzki Marc^ORCID

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference43 articles.

1. Immunopathology of multiple sclerosis;Dendrou;Nat. Rev. Immunol.,2015

2. Epidemiologie der Multiplen Sklerose in Deutschland: Regionale Unterschiede und Versorgungsstruktur in Abrechnungsdaten der gesetzlichen Krankenversicherung;Petersen;Nervenarzt,2014

3. Relapsing and progressive forms of multiple sclerosis – insights from pathology;Dutta;Curr. Opin. Neurol.,2014

4. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability;Weinshenker;Brain J. Neurol.,1989

5. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis;Brown;JAMA,2019

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting multiple sclerosis disease progression and outcomes with machine learning and MRI-based biomarkers: a review;Journal of Neurology;2024-09-12

2. Characterization of Japanese multiple sclerosis patients with progression independent of relapse activity: A 2-year multicenter cohort study;Journal of Neuroimmunology;2024-09

3. Prevalence of elevated sNFL in a real-world setting: Results on 908 patients with different multiple sclerosis types and treatment conditions;Multiple Sclerosis and Related Disorders;2024-08

4. Disability patterns in multiple sclerosis: A meta-analysis on RAW and PIRA in the real-world context;Multiple Sclerosis Journal;2024-07-31

5. Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple Sclerosis;Neurology;2024-07-09